Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01538264 · ClinicalTrials.gov registry record
Blood Flow MRI for Monitoring Brain Tumors
A clinical trial of Brain Tumors, sponsored by Beth Israel Deaconess Medical Center.
- Active
- Registry status
- 125
- Enrollment target
- 1
- Study location
NCT01538264 is a study of Brain Tumors that is active but no longer recruiting, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 125 participants, below the 6,330-participant average among 10 other Brain Tumors trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01538264, a study of Brain Tumors, is active but no longer recruiting, sponsored by Beth Israel Deaconess Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- 125 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators are studying the use of an advanced magnetic resonance imaging (MRI) technique for measuring blood flow into brain tumors. This technique does not use radioactive tracers, and it can provide high quality images that can be obtained in a standard MRI scanner.
Conditions Studied
Study Locations (1)
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2006-06 |
| Est. Completion | 2025-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01538264
The ClinicalTrials.gov registry entry for NCT01538264 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 6,330-participant average among 10 other Brain Tumors trials with a reported enrollment target (98% lower). The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Brain Tumors appearing as the primary indexed condition, and to 0 interventions.
NCT01538264 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01538264 about?
NCT01538264 is a clinical study titled "Blood Flow MRI for Monitoring Brain Tumors". The investigators are studying the use of an advanced magnetic resonance imaging (MRI) technique for measuring blood flow into brain tumors. This technique does not use radioactive tracers, and it can provide high quality images that can be obtained in a standard MRI scanner.
What is the current status of trial NCT01538264?
This trial is currently active not recruiting. The enrollment target is 125 participants. The study started on 2006-06. Estimated completion is 2025-12-31.
What conditions does trial NCT01538264 study?
This clinical trial studies the following conditions: Brain Tumors.
Who is sponsoring clinical trial NCT01538264?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01538264 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain Tumors
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Florida Center for Brain Tumor Research
RECRUITING
-
Prospective Assessment of Quality of Life (QOL) in Pediatric Patients Treated With Radiation Therapy for Brain Tumors and Non-central Nervous System (Non-CNS) Malignancies
ACTIVE NOT RECRUITING
-
Enrollment on the Childhood Cancer Research Network (CCRN) of the Children's Oncology Group
ACTIVE NOT RECRUITING
-
ALA-induced PpIX Fluorescence During Brain Tumor Resection
ACTIVE NOT RECRUITING · Phase 1
-
Study of Systemic and Spinal Chemotherapy Followed by Radiation for Infants With Brain Tumors
COMPLETED · NA
-
[F-18] Fluorothymidine (FLT) Imaging on Patients With Primary Brain Tumors
COMPLETED · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.